2-Bromo-4'-hydroxyacetophenone
Based on 1 Customer Validation
2-Bromo-4'-hydroxyacetophenone is a PTP1B inhibitor with a Ki value of 42 μM. 2-Bromo-4'-hydroxyacetophenone is also an intermediate. 2-Bromo-4'-hydroxyacetophenone can be used in the synthesis of LXRα/β antagonists. 2-Bromo-4'-hydroxyacetophenone can be used in research on hematological diseases.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- Purity: 98.57%
- CAS No.: 2491-38-5
- 화학식: C8H7BrO2
- 분자량:215.05
-
보관:
4°C, stored under nitrogen, away from moisture
* The compound is unstable in solutions, freshly prepared is recommended.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
-
용액&용해도
- 순도&문서
- References
-
Help & FAQs
Biological Activity
Ki: 42 μM (PTP1B)[1].
Chemical Information
-
CAS No. 2491-38-5
-
Appearance Solid
-
분자량 215.05
-
화학식 C8H7BrO2
-
Color White to off-white
-
SMILES
OC1=CC=C(C(CBr)=O)C=C1
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
4°C, stored under nitrogen, away from moisture
* The compound is unstable in solutions, freshly prepared is recommended.
용액&용해도
DMSO : 200 mg/mL (930.02 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Methanol : 125 mg/mL (581.26 mM; Need ultrasonic)
Please refer to the solubility information to select the appropriate solvent. The compound is unstable in solutions, freshly prepared is recommended.
Please refer to the solubility information to select the appropriate solvent. The compound is unstable in solutions, freshly prepared is recommended.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.08 mg/mL (9.67 mM); Clear solution
This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.08 mg/mL (9.67 mM); Clear solution
This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL. * The compound is unstable in solutions, freshly prepared is recommended.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
순도&문서
-
Data Sheet (271 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. The compound is unstable in solutions, freshly prepared is recommended.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| Methanol / DMSO | 1 mM | 4.6501 mL | 23.2504 mL | 46.5008 mL | 116.2520 mL |
| 5 mM | 0.9300 mL | 4.6501 mL | 9.3002 mL | 23.2504 mL | |
| 10 mM | 0.4650 mL | 2.3250 mL | 4.6501 mL | 11.6252 mL | |
| 15 mM | 0.3100 mL | 1.5500 mL | 3.1001 mL | 7.7501 mL | |
| 20 mM | 0.2325 mL | 1.1625 mL | 2.3250 mL | 5.8126 mL | |
| 25 mM | 0.1860 mL | 0.9300 mL | 1.8600 mL | 4.6501 mL | |
| 30 mM | 0.1550 mL | 0.7750 mL | 1.5500 mL | 3.8751 mL | |
| 40 mM | 0.1163 mL | 0.5813 mL | 1.1625 mL | 2.9063 mL | |
| 50 mM | 0.0930 mL | 0.4650 mL | 0.9300 mL | 2.3250 mL | |
| 60 mM | 0.0775 mL | 0.3875 mL | 0.7750 mL | 1.9375 mL | |
| 80 mM | 0.0581 mL | 0.2906 mL | 0.5813 mL | 1.4532 mL | |
| 100 mM | 0.0465 mL | 0.2325 mL | 0.4650 mL | 1.1625 mL |
2-Bromo-4'-hydroxyacetophenone Related Classifications
HY-W002314 Related Classifications
Powered by Bioz